The extreme arrogance of anti-aging medicine

Robin Holliday1

  • 1Australian Academy of Science, Canberra, Australia. RandL.Holliday@bigpond.com

Biogerontology
|August 30, 2008
PubMed

Insights

The anti-aging medicine movement aims to reverse human aging and achieve extreme longevity by addressing age-associated diseases. This ambitious goal contrasts with the slow, evolutionary processes that determine lifespan.

Area of Science:

  • Gerontology and Regenerative Medicine
  • Evolutionary Biology

Background:

  • The anti-aging medicine movement seeks to significantly extend human lifespan.
  • This field proposes interventions to reverse or bypass the multiple causes of aging.
  • Aging is a complex process influenced by numerous age-associated pathologies.

Purpose of the Study:

  • To critically evaluate the claims and scientific basis of the anti-aging medicine movement.
  • To contrast the movement's goals with the established understanding of aging as an evolutionary process.

Main Methods:

  • Analysis of the scientific literature on aging and age-associated diseases.
  • Examination of the evolutionary history and biological underpinnings of lifespan.
  • Comparative assessment of the anti-aging movement's proposed timeline versus biological realities.

Main Results:

  • The anti-aging movement posits that human aging can be reversed within decades.
  • Current research focuses on understanding numerous age-associated pathologies individually.
  • Aging is presented as a product of millions of years of evolution, deeply integrated into animal physiology.

Conclusions:

  • The anti-aging movement's objective to rapidly reverse evolutionary aging processes is highly ambitious.
  • The movement's claims may overstate the potential for near-term, radical life extension.
  • A significant gap exists between the proposed interventions and the deep-rooted biological mechanisms of aging.

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Affinity and Avidity01:41

Affinity and Avidity

Overview
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...